As of Feb 22
| +0.11 / +0.29%|
The 1 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 65.00, with a high estimate of 65.00 and a low estimate of 65.00. The median estimate represents a +68.26% increase from the last price of 38.63.
The current consensus among 1 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.